pI: 7.0444 |
Length (AA): 378 |
MW (Da): 43743 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_129642)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G42970 | COP9 signalosome complex subunit 4 |
Brugia malayi | Bm1_40815 | PCI domain containing protein |
Caenorhabditis elegans | CELE_Y55F3AM.15 | Protein CSN-4 |
Dictyostelium discoideum | DDB_G0293844 | COP9 signalosome complex subunit 4 |
Drosophila melanogaster | Dmel_CG8725 | COP9 complex homolog subunit 4 |
Echinococcus granulosus | EgrG_000688950 | cop9 complex subunit |
Echinococcus multilocularis | EmuJ_000688950 | cop9 complex subunit |
Homo sapiens | ENSG00000138663 | COP9 signalosome subunit 4 |
Loa Loa (eye worm) | LOAG_04090 | PCI domain-containing protein |
Mus musculus | ENSMUSG00000035297 | COP9 (constitutive photomorphogenic) homolog, subunit 4 (Arabidopsis thaliana) |
Oryza sativa | 4331948 | Os03g0197400 |
Schistosoma japonicum | Sjp_0046570 | COP9 signalosome complex subunit 4, putative |
Schistosoma mansoni | Smp_085640.1 | cop9 complex subunit |
Schistosoma mansoni | Smp_085640.2 | cop9 complex subunit |
Schmidtea mediterranea | mk4.000528.11 | COP9 signalosome complex subunit 4 |
Trypanosoma brucei gambiense | Tbg972.10.9560 | cop9 signalosome complex subunit, putative,predicted PCI domain protein |
Trypanosoma brucei | Tb927.10.7800 | cop9 signalosome complex subunit, putative |
Trypanosoma congolense | TcIL3000_10_6660 | predicted PCI domain protein |
Trypanosoma cruzi | TcCLB.503779.100 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.506247.460 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_043930 | COP9 signalosome complex subunit, putative |
Trichomonas vaginalis | TVAG_492560 | COP9 signalosome complex subunit, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.7800 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.7800 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.7800 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.7800 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y55F3AM.15 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y55F3AM.15 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_Y55F3AM.15 | Caenorhabditis elegans | sterile | wormbase |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.